Afynia is a startup based in Canada. Brouky records 1 investor associated with the company.
Afynia offers a microRNA-based blood test to detect endometriosis. The company develops a molecular diagnostic intended to provide a non-invasive diagnostic option for this condition.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.